nach oben

Reactions Weekly

Erschienen in:

01.04.2015 | Case report

Infliximab

Infusion reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

A retrospective study identified a patient [age and sex not stated] who developed infusion reaction while receiving infliximab [Remicade]. The patient, who had a history of steroid and tacrolimus refractory ulcerative colitis, started receiving 2-hour IV infusions of infliximab 5 mg/kg body weight. The patient experienced a mild infusion reaction [time to reaction onset not stated]; discontinuation of treatment was not required. …

Yamamoto S, et al. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Journal of Gastroenterology and Hepatology 25: 886-891, No. 5, May 2010. Available from: URL: http://doi.org/10.1111/j.1440-1746.2009.06206.x - JapanCrossRefPubMed

Titel: Infliximab
Infusion reaction: case report
Publikationsdatum: 01.04.2015
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9963-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Infliximab

Infusion reaction: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Norepinephrine

Recombinant factor-viia

Risperidone

Siagoside

Adalimumab

Doxazosin